Description

NSE Clearing publishes the revised list of 178+ securities eligible for transactions in the Securities Lending & Borrowing Scheme (SLBS) for January 2026.

Summary

NSE Clearing Limited has issued the revised list of securities available for transactions in the Securities Lending & Borrowing Scheme (SLBS) for January 2026. This circular references SEBI circular CIR/MRD/DP/18/2013 dated May 30, 2013 and NSE Clearing’s consolidated circular NCL/CMPT/67763 dated April 30, 2025. The list contains 178+ securities eligible for SLBS transactions.

Key Points

  • Circular Reference Number: NCL/CMPT/72024 (Circular 144/2025)
  • Effective Period: January 2026
  • Total securities listed: 178+ stocks (partial list shown)
  • Addressed to all SLBS participants and custodians
  • Securities span multiple sectors including pharmaceuticals, manufacturing, financial services, technology, and infrastructure

Regulatory Changes

No regulatory changes introduced. This is a routine monthly update to the list of eligible securities for SLBS transactions in accordance with existing SEBI guidelines.

Compliance Requirements

  • All SLBS participants and custodians must refer to Annexure-I for the complete list of eligible securities
  • Only securities listed in the annexure are available for lending and borrowing transactions during January 2026
  • Participants should ensure their SLBS transactions comply with the updated eligible securities list

Important Dates

  • Circular Issue Date: December 26, 2025
  • Applicable Period: January 2026

Impact Assessment

Market Impact: Medium - The revised list affects liquidity and availability of securities for lending/borrowing operations. Inclusion or exclusion of specific securities may impact short-selling strategies and hedging activities.

Operational Impact: Low to Medium - Participants need to update their systems and verify eligibility before executing SLBS transactions in January 2026.

Sector Coverage: The list includes diverse sectors - blue-chip companies (3M India, Abbott India), mid-cap stocks, and emerging companies across pharmaceuticals, automobiles, financial services, chemicals, technology, real estate, and infrastructure.

Contact Information: For queries, participants can contact NSE Clearing at 18002660050 (IVR Option 2) or email support@nsccl.co.in.

Impact Justification

Routine monthly update of SLBS eligible securities list. Important for participants in securities lending/borrowing but represents normal operational maintenance rather than policy change.